PACS1 Protein is a protein encoded by the [PACS1](/genes/pacs1) gene. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target. [@schuurshoeijmakers2019]
PACS1 Protein is a protein encoded by the [PACS1](/genes/pacs1) gene. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target. [@schuurshoeijmakers2019]
The protein serves as a cargo adaptor for membrane protein trafficking between the trans-Golgi network, endosomes, and the plasma membrane [1](https://doi.org/10.1083/jcb.200104079).
Normal Function in the Nervous System
In [neurons](/entities/neurons), PACS1 regulates:
Synaptic vesicle trafficking: Controls neurotransmitter release through sorting of synaptic proteins
Receptor endocytosis: Manages trafficking of neurotransmitter receptors (AMPA, NMDA, GABA)
Protein sorting: Directs membrane proteins to their proper cellular compartments
Dendritic spine morphology: Influences synaptic structure and plasticity
Axonal cargo transport: Participates in axonal trafficking pathways
PACS1 is widely expressed in neurons and is essential for maintaining synaptic function [2](https://doi.org/10.1016/j.neurobiolaging.2019.02.015).
Role in Disease
Alzheimer's Disease (AD)
PACS1-mediated trafficking is disrupted in AD neurons
Altered sorting of [amyloid precursor protein](/entities/app-protein) (APP) and [BACE1](/entities/bace1)
Contributes to [Aβ](/proteins/amyloid-beta) production through mislocalization of processing enzymes
Synaptic vesicle trafficking deficits link to cognitive decline [3](https://pubmed.ncbi.nlm.nih.gov/30766923/)
Parkinson's Disease (PD)
Regulates trafficking of dopamine receptors
Involved in endosomal sorting of [alpha-synuclein](/proteins/alpha-synuclein)
May affect Lewy body formation through protein sorting defects
DJ-1 and PACS1 interactions in PD pathogenesis
Intellectual Disability
PACS1 mutations cause syndromic intellectual disability (Schuurs-Hoeijmakers syndrome)
Characterized by developmental delay, dysmorphic features, and autism
Heterozygous missense mutations are the primary cause
Epilepsy
Altered PACS1 expression in epileptic brain tissue
Contributes to synaptic dysfunction in seizure disorders
Therapeutic Targeting
No direct PACS1-targeted drugs are currently available
Viral-mediated gene therapy: Under investigation for PACS1-related disorders
Modulators of membrane trafficking: Indirect therapeutic approach
Key Publications
[PACS-1 as a sorting adaptor for membrane protein trafficking (2001)](https://doi.org/10.1083/jcb.200104079)
[PACS1 in aging and neurodegenerative disease (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.02.015)
[PACS1 mutations and intellectual disability syndrome (2019)](https://pubmed.ncbi.nlm.nih.gov/30766923/)
[Membrane trafficking in Alzheimer's disease (2020)](https://doi.org/10.1016/j.tcb.2020.01.004)